Teams at Kriya Therapeutics, Inc.

Provide scientific leadership across clinical study lifecycle including protocol and regulatory document development, study design support, data review and analysis, vendor and investigator selection oversight, training, and preparation of abstracts, manuscripts, and clinical study reports to ensure scientific quality and compliance.

The Vice President, Pharmacovigilance oversees safety surveillance programs, evaluates adverse events, ensures regulatory compliance, and collaborates with teams on risk management strategies.

The Senior Director of Pharmacovigilance leads safety surveillance for gene therapy products, ensuring compliance with regulations and executing safety strategies across Kriya's portfolio.